Please use this identifier to cite or link to this item:
|Title:||Supplier behavior and product quality in Indian pharmaceutical markets: Implications for price regulation and patent enforcement from pharmaceutical demand in India||Authors:||Chatterjee, Chirantan
|Keywords:||Pharmaceutical industry;Indian pharmaceutical industry;Pharmaceutical markets;Supplier behavior;Pharmaceutical innovations||Issue Date:||6-Jan-2012||Publisher:||Indian Institute of Management Bangalore||Project:||Supplier behavior and product quality in Indian pharmaceutical markets: Implications for price regulation and patent enforcement from pharmaceutical demand in India||Series/Report no.:||IIMB_PR_2011-12_013||Abstract:||The Indian pharmaceutical industry is characterized by intense inter-firm competition and a high degree of heterogeneity in product quality. The former aspect is due to the lack of patent protection for pharmaceutical innovations – except for those relating to manufacturing processes – until 2005, and the existence of a thriving local generic drug industry. These are the same factors that have in recent times contributed to India’s rise as one of the world’s largest producers and exporters of generic pharmaceuticals (Chaudhuri, 2005).||URI:||https://repository.iimb.ac.in/handle/2074/21403|
|Appears in Collections:||2011-2012|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.